3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers

3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers

Submitted by admin on August 19, 2011 - 9:20am
Source: 
Marketwatch
News Tags: 
Dendreon
Provenge
Savient
Human Genome Sciences
Vertex Pharmaceuticals
InterMune
Seattle Genetics
Headline: 
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers

Do Not Allow Advertisers to Use My Personal information